Could a home device replace hospital trips for diabetic eye disease?
NCT ID NCT06610747
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This trial investigates whether people with diabetic macular edema can safely monitor their vision and eye health at home instead of making frequent hospital visits. Participants use a home vision tester and a portable eye scanner every four weeks, with results sent to their doctor. The study compares vision outcomes over 96 weeks between home-based and standard clinic-based care.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Home-based monitoring (self-administered visual acuity test and OCT device)
- What this could lead to
- If successful, this approach could allow people with diabetic macular edema to manage their condition from home, reducing the need for frequent hospital visits.
- What could go wrong
- This is a mid-stage trial with 308 participants, and home devices may not detect complications as reliably as in-clinic exams. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dongguan Guangming Ophthalmic Hospital
RECRUITINGDongguan, Guangdong, China
-
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510000, China
-
The First Affiliated Hospital of Jinan University
RECRUITINGGuangzhou, Guangdong, 510000, China
-
The Second Peoples Hospital of Foshan
RECRUITINGFoshan, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye injection preserve vision in south asians with diabetes?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
- Can a steroid implant boost the effect of standard eye injections for hard-to-treat diabetic macular edema?
- Eye injection aims to tame leading causes of blindness
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling